摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3aS,4R,6aR)-2,2-dimethyl-5-oxo-3a,4,6,6a-tetrahydroselenopheno[3,4-d][1,3]dioxol-4-yl]methoxy-tert-butyl-diphenylsilane | 1006032-31-0

中文名称
——
中文别名
——
英文名称
[(3aS,4R,6aR)-2,2-dimethyl-5-oxo-3a,4,6,6a-tetrahydroselenopheno[3,4-d][1,3]dioxol-4-yl]methoxy-tert-butyl-diphenylsilane
英文别名
——
[(3aS,4R,6aR)-2,2-dimethyl-5-oxo-3a,4,6,6a-tetrahydroselenopheno[3,4-d][1,3]dioxol-4-yl]methoxy-tert-butyl-diphenylsilane化学式
CAS
1006032-31-0
化学式
C24H32O4SeSi
mdl
——
分子量
491.561
InChiKey
KTHLGIMCZTVWQE-DBJIZHOSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.89
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [(3aS,4R,6aR)-2,2-dimethyl-5-oxo-3a,4,6,6a-tetrahydroselenopheno[3,4-d][1,3]dioxol-4-yl]methoxy-tert-butyl-diphenylsilane吡啶三氟甲磺酸三甲基硅酯三乙胺三氟乙酸 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 34.33h, 生成 1-[3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-4-seleno-β-D-ribofuranosyl]thymine
    参考文献:
    名称:
    Structure–activity relationships of 2′-modified-4′-selenoarabinofuranosyl-pyrimidines as anticancer agents
    摘要:
    Based on the potent anticancer activity of the D-arabino-configured cytosine nucleoside ara-C, novel 2'-substituted-4'-selenoarabinofuranosyl pyrimidines 3a-3u, comprising azido, fluoro, and hydroxyl substituents at C-2' were designed, synthesized, and evaluated for anticancer activity. The 2'-azido group was stereoselectively introduced by the Mitsunobu reaction using diphenylphosphoryl azide (DPPA), and the 2'-fluoro group was stereoselectively introduced through the double inversions of stereochemistry via the episelenium intermediate, which was formed by the participation of the selenium atom. Among the compounds tested, the 2'-fluoro derivative 3t (X = NH2, Y = H, R = F) was found to be the most potent anticancer agent and showed more potent anticancer activity than the control, ara-C in all tested human cancer cell lines (HCT116, A549, SNU638, T47D, and PC-3) except the leukemia cell lines (K562). The anticancer activity of the 2'-substituted-4'-selenonucleosides is in the following order: 2'-F > 2'-OH > 2'-N3.
    DOI:
    10.1016/j.ejmech.2014.06.031
  • 作为产物:
    参考文献:
    名称:
    Structure–activity relationships of 2′-modified-4′-selenoarabinofuranosyl-pyrimidines as anticancer agents
    摘要:
    Based on the potent anticancer activity of the D-arabino-configured cytosine nucleoside ara-C, novel 2'-substituted-4'-selenoarabinofuranosyl pyrimidines 3a-3u, comprising azido, fluoro, and hydroxyl substituents at C-2' were designed, synthesized, and evaluated for anticancer activity. The 2'-azido group was stereoselectively introduced by the Mitsunobu reaction using diphenylphosphoryl azide (DPPA), and the 2'-fluoro group was stereoselectively introduced through the double inversions of stereochemistry via the episelenium intermediate, which was formed by the participation of the selenium atom. Among the compounds tested, the 2'-fluoro derivative 3t (X = NH2, Y = H, R = F) was found to be the most potent anticancer agent and showed more potent anticancer activity than the control, ara-C in all tested human cancer cell lines (HCT116, A549, SNU638, T47D, and PC-3) except the leukemia cell lines (K562). The anticancer activity of the 2'-substituted-4'-selenonucleosides is in the following order: 2'-F > 2'-OH > 2'-N3.
    DOI:
    10.1016/j.ejmech.2014.06.031
点击查看最新优质反应信息

文献信息

  • Practical synthesis of 4′-selenopurine nucleosides by combining chlorinated purines and ‘armed’ 4-selenosugar
    作者:Kazuki Ishii、Noriko Saito-Tarashima、Masashi Ota、Seigi Yamamoto、Yasuko Okamoto、Yoshiyuki Tanaka、Noriaki Minakawa
    DOI:10.1016/j.tet.2016.08.071
    日期:2016.10
    The synthesis of a variety of chemically modified oligonucleotides requires the development of a practical synthetic method for its building block, i.e., nucleoside analogs. The one-pot Pummerer-like reaction using hypervalent iodine in combination with 6-chloropurine and an ‘armed’ 4-selenosugar bearing an electron-donating group at the 2-position gave the desired 4′-seleno-6-chloropurine derivative
    多种化学修饰的寡核苷酸的合成需要开发一种实用的合成方法作为其基本组成部分,即核苷类似物。使用高价碘与6-氯嘌呤和在2位带有供电子基团的“武装” 4-硒代糖结合使用的一锅Pummerer样反应,可得到所需的4'-硒代-6-氯嘌呤衍生物。与使用“解除武装”的4-硒代糖的2-位带有吸电子基团的先前方法相比,产率更高。另外,使用2,6-二氯嘌呤作为可转化为鸟嘌呤骨架的核碱基能够实现有效的Pummerer样反应,然后在酸性条件下异构化为所需的N9异构体。
  • New RNA Purine Building Blocks, 4′-Selenopurine Nucleosides: First Synthesis and Unusual Mixture of Sugar Puckerings
    作者:Jinha Yu、Jin-Hee Kim、Hyuk Woo Lee、Varughese Alexander、Hee-Chul Ahn、Won Jun Choi、Jungwon Choi、Lak Shin Jeong
    DOI:10.1002/chem.201300741
    日期:2013.4.26
    Writer's blocks: The first synthesis of RNA purine building blocks, 4′‐selenoadenosine and 4′‐selenoguanosine was achieved from D‐ribose by regioisomeric rearrangement, which was confirmed by X‐ray crystallography. 4′‐Selenoadenosine exists in an unusual mixture of north and south conformers in the solid state.
    作者的区块:通过区域异构体重排由D-核糖实现了RNA嘌呤结构单元4'-硒腺苷和4'-硒鸟苷的首次合成,这一点已通过X射线晶体学证实。4'-硒腺苷以固态的北部和南部构象异构体的混合物存在。
  • Stereoselective Synthesis and Conformational Study of Novel 2′,3′-Didehydro-2′,3′-dideoxy-4′-selenonucleosides
    作者:Dilip K. Tosh、Won Jun Choi、Hea Ok Kim、Yoonji Lee、Shantanu Pal、Xiyan Hou、Jungwon Choi、Sun Choi、Lak Shin Jeong
    DOI:10.1021/jo8003277
    日期:2008.6.1
    Stereoselective synthesis of novel 2',3'-didehydro-2',3'dideoxy-4'-selenonnucleosides (4'-seleno-d4Ns) 4a-c was accomplished via 4'-selenoribofuranosyl pyrimidines 11a-c, as key intermediates. 4'-Selenoribofuranosyl pyrimidines 11a-c were efficiently synthesized from D-ribose or D-gulonic gamma-lactone using a Pummerer-type condensation as a key step. Introduction of 2',3'-double bond was achieved by treating cyclic 2',3'-thiocarbonate with 1,3-dimethyl-2-phenyl-1,3,2-diazaphospholidine.
  • First Synthesis of 4‘-Selenonucleosides Showing Unusual Southern Conformation
    作者:Lak Shin Jeong、Dilip K. Tosh、Hea Ok Kim、Ting Wang、Xiyan Hou、Ho Seop Yun、Youngjoo Kwon、Sang Kook Lee、Jungwon Choi、Long Xuan Zhao
    DOI:10.1021/ol7025558
    日期:2008.1.1
    The first synthesis of 4'-selenonucleosides was achieved using a Pummerer-type condensation as a key step. All stereoelectronic effects shown in 4'-oxonucleosides were overwhelmed by the size of selenium and steric interactions, driving the conformation to the C2'-endol C3'-exo twist (Southern) conformation.
  • Structure–activity relationships of 2′-modified-4′-selenoarabinofuranosyl-pyrimidines as anticancer agents
    作者:Jin-Hee Kim、Jinha Yu、Varughese Alexander、Jung Hee Choi、Jayoung Song、Hyuk Woo Lee、Hea Ok Kim、Jungwon Choi、Sang Kook Lee、Lak Shin Jeong
    DOI:10.1016/j.ejmech.2014.06.031
    日期:2014.8
    Based on the potent anticancer activity of the D-arabino-configured cytosine nucleoside ara-C, novel 2'-substituted-4'-selenoarabinofuranosyl pyrimidines 3a-3u, comprising azido, fluoro, and hydroxyl substituents at C-2' were designed, synthesized, and evaluated for anticancer activity. The 2'-azido group was stereoselectively introduced by the Mitsunobu reaction using diphenylphosphoryl azide (DPPA), and the 2'-fluoro group was stereoselectively introduced through the double inversions of stereochemistry via the episelenium intermediate, which was formed by the participation of the selenium atom. Among the compounds tested, the 2'-fluoro derivative 3t (X = NH2, Y = H, R = F) was found to be the most potent anticancer agent and showed more potent anticancer activity than the control, ara-C in all tested human cancer cell lines (HCT116, A549, SNU638, T47D, and PC-3) except the leukemia cell lines (K562). The anticancer activity of the 2'-substituted-4'-selenonucleosides is in the following order: 2'-F > 2'-OH > 2'-N3.
查看更多